Phase II trial of DM-199 for the treatment of chronic kidney disease in type 1 diabetic patients

Trial Profile

Phase II trial of DM-199 for the treatment of chronic kidney disease in type 1 diabetic patients

Planning
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2018

At a glance

  • Drugs DM 199 (Primary)
  • Indications Diabetic nephropathies
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2018 New trial record
    • 18 Jan 2018 According to a DiaMedica Therapeutics media release, meeting with FDA is planned in Q1 2018 to discuss this trial and the regulatory path forward.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top